Language
Novel antibodies show promise for tumor targeting and RAD51 inhibition

Blog

HomeHome / Blog / Novel antibodies show promise for tumor targeting and RAD51 inhibition
search

May 20, 2023

Autophagy

Jun 09, 2023

Super

Oct 29, 2023

Statement on the antigen composition of COVID

Jul 18, 2023

Postoperative serum interleukin

Jun 11, 2023

Recombinant Protein Market is Projected To Reach A Revised Size of USD 2,320.21 Million By 2029, Growing At A CAGR of 13.02%

Send your inquiry
SUBMIT

Oct 22, 2024

Novel antibodies show promise for tumor targeting and RAD51 inhibition

Rabi Musah In this interview conducted at Pittcon 2024 in San Diego, Rabi Musah delves into her innovative use of DART-HRMS and chemometric analysis to differentiate between hemp and marijuana

Rabi Musah

In this interview conducted at Pittcon 2024 in San Diego, Rabi Musah delves into her innovative use of DART-HRMS and chemometric analysis to differentiate between hemp and marijuana varieties of Cannabis sativa, exploring the forensic and legal implications of these findings.